Related Experiment Video
Updated: Aug 14, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Cerebral microbleeds are common in ischemic stroke but rare in TIA
D J Werring1, L J Coward, N A Losseff
1Stroke Research Group, Institute of Neurology, University College London, National Hospital for Neurology and Neurosurgery, London, UK.
Background:
In patients with stroke, gradient-echo MRI commonly detects microbleeds, indicating small artery disease with increased risk of macroscopic intracranial bleeding. Antithrombotic treatments are frequently prescribed after TIA and stroke, but there have been no previous studies of microbleeds in TIA. Because microbleeds may predict the hemorrhagic risk of antithrombotic treatments, we studied the prevalence of microbleeds, risk factors, and pathophysiologic mechanisms in patients with ischemic stroke and TIA.
Methods:
One hundred twenty-nine consecutive patients with ischemic stroke or TIA were studied with MRI including T2, fluid-attenuated inversion recovery, and gradient-echo MRI sequences. Blinded observers counted microbleeds and graded white matter T2 hyperintensities throughout the brain. TIA patients with previous ischemic stroke were excluded.
Results:
Sixty-seven percent of patients had ischemic stroke; 33% had TIA. Microbleeds were found in 23% of ischemic stroke patients but only 2% of TIA patients (p < 0.001). There were no significant differences in conventional risk factors or the severity of white matter disease on T2 MRI between stroke and TIA patients. Patients with microbleeds were more often hypertensive (81 vs 59%; p = 0.04) and had more severe MRI white matter disease on T2 MRI (p = 0.003).
Conclusions:
Microbleeds are common in ischemic stroke but rare in TIA, an observation not explained by differences in vascular risk factors or severity of white matter disease seen on T2 MRI. This finding has implications for the safety of antithrombotic therapy and clinical trial design in the two groups. Microbleeds may also be a new marker for severe microvascular pathology with increased risk of permanent cerebral infarction.
Insights
Microbleeds are common in ischemic stroke but rare in transient ischemic attack (TIA). This difference is not explained by typical risk factors, impacting antithrombotic therapy safety and clinical trial design.
Area of Science:
- Neurology
- Radiology
- Vascular Medicine
Background:
- Gradient-echo MRI frequently detects microbleeds in stroke patients, indicating small artery disease and increased bleeding risk.
- Antithrombotic treatments are common post-stroke/TIA, yet microbleed prevalence in TIA remains unstudied.
- Microbleeds may predict hemorrhagic risk associated with antithrombotic therapies.
Purpose of the Study:
- To investigate the prevalence of microbleeds in patients with ischemic stroke and transient ischemic attack (TIA).
- To identify risk factors and pathophysiologic mechanisms associated with microbleeds in these patient groups.
- To assess the clinical implications of microbleed detection for treatment and research.
Main Methods:
- 129 consecutive patients with ischemic stroke or TIA underwent MRI (T2, FLAIR, gradient-echo).
- Blinded observers quantified microbleeds and graded white matter T2 hyperintensities.
- Patients with prior ischemic stroke were excluded from the TIA group.
Main Results:
- Microbleeds were detected in 23% of ischemic stroke patients versus 2% of TIA patients (p < 0.001).
- No significant differences in conventional risk factors or white matter disease severity between stroke and TIA groups.
- Microbleed presence correlated with hypertension (81% vs 59%, p=0.04) and more severe white matter disease (p=0.003).
Conclusions:
- Microbleeds are significantly more common in ischemic stroke than TIA, irrespective of vascular risk factors or white matter disease severity.
- Findings impact the safety considerations for antithrombotic therapy and clinical trial design in stroke versus TIA.
- Microbleeds may serve as a novel biomarker for severe microvascular pathology and heightened risk of cerebral infarction.
Related Concept Videos
Transient Ischemic Attack l: Introduction
Hemorrhagic Stroke l: Introduction
Ischemic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Stroke: Introduction and Types

